Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.51 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.51 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5665518 | 0.92 | HTR2C (0.69) | HTR2CDGKAPRSS1PRSS2PRSS3 | |
| SCHEMBL23982999 | 0.92 | HTR2C (0.69) | HTR2CDGKAPRSS1PRSS2PRSS3 | |
| SCHEMBL13493855 | 0.92 | DGKA (0.61) | HTR2CDGKAPRSS1PRSS2PRSS3 | |
| SCHEMBL28860834 | 0.92 | DGKA (0.67) | HTR2CDGKAPRSS1PRSS2PRSS3 | |
| Dibutylsuccinate SCHEMBL50411 | 0.89 | DGKA (0.67) | HTR2CDGKAPRSS1PRSS2PRSS3 | |
| Dibutylsuccinate SCHEMBL3977806 | 0.89 | DGKA (0.67) | HTR2CDGKAPRSS1PRSS2PRSS3 | |
| Palmitamide SCHEMBL8397170 | 0.88 | DGKA (0.74) | HTR2CDGKAPRSS1PRSS2PRSS3 | |
| SCHEMBL28271588 | 0.88 | DGKA (0.74) | HTR2CDGKAPRSS1PRSS2PRSS3 | |
| Octadecanoic Acid Amide SCHEMBL6244875 | 0.88 | DGKA (0.74) | HTR2CDGKAPRSS1PRSS2PRSS3 | |
| Dibutylsuccinate SCHEMBL7705415 | 0.87 | HTR2C (0.67) | HTR2CDGKAPRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104981694-A | Lipid membrane encapsulated particles with membrane proteins | AIT AUSTRIAN INST TECHNOLOGY | 2015-10-14 | — | — | CN | disclosed |
| CN-102898395-B | Method for preparing 4-methyl-5-n-butoxy oxazole | DAFENG HEGNO PHARMACEUTICALS CO LTD | 2015-03-11 | — | — | CN | disclosed |
| US-8410306-B2 | Method of producing a carboxylic alkyl ester | BASF SE (DE) | 2013-04-02 | — | — | US | disclosed |
| US-8410306-B2 | Method of producing a carboxylic alkyl ester | BASF SE (DE) | 2013-04-02 | — | — | US | disclosed |
| CN-102898395-A | Method for preparing 4-methyl-5-n-butoxy oxazole | DAFENG HAIJIANUO PHARMACEUTICAL CO LTD | 2013-01-30 | — | — | CN | disclosed |
| EP-2266954-A1 | Novel bifunctional chelating compounds containing hydroxamic acid residues | Draximage, Inc. (CA) | 2010-12-29 | — | — | EP | disclosed |
| EP-2266953-A1 | Novel bifunctional chelating compounds containing hydroxamic acid residues | Draximage, Inc. (CA) | 2010-12-29 | — | — | EP | disclosed |
| US-20090137825-A1 | METHOD OF PRODUCING A CARBOXYLIC ALKYL ESTER | BASF AKTIENGESELLSCHAFT (DE) | 2009-05-28 | — | — | US | disclosed |
| US-20090137825-A1 | METHOD OF PRODUCING A CARBOXYLIC ALKYL ESTER | BASF AKTIENGESELLSCHAFT (DE) | 2009-05-28 | — | — | US | disclosed |
| WO-2007116005-A1 | METHOD OF PRODUCING A CARBOXYLIC ALKYL ESTER | BASF SE (DE) | 2007-10-18 | — | — | WO | disclosed |
| US-6506772-B1 | Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. | HOFFMANN-LA ROCHE INC. | 2003-01-14 | — | — | US | disclosed |
| CN-1314906-A | Salts of paroxetine | SMITHKLINE BEECHAM PLC (GB) | 2001-09-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137825-A1 | METHOD OF PRODUCING A CARBOXYLIC ALKYL ESTER | CPS1, ACMSD, PCCA | HTR2C 4439/4885DGKA 354/4885PRSS1 4389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.